These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24332384)

  • 21. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
    O'Reardon JP; Solvason HB; Janicak PG; Sampson S; Isenberg KE; Nahas Z; McDonald WM; Avery D; Fitzgerald PB; Loo C; Demitrack MA; George MS; Sackeim HA
    Biol Psychiatry; 2007 Dec; 62(11):1208-16. PubMed ID: 17573044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study.
    Yıldız T; Oğuzhanoğlu NK; Topak OZ
    Turk J Med Sci; 2023 Feb; 53(1):253-263. PubMed ID: 36945926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.
    Rosenquist PB; Krystal A; Heart KL; Demitrack MA; McCall WV
    Psychiatry Res; 2013 Jan; 205(1-2):67-73. PubMed ID: 23021320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.
    Greer TL; Trombello JM; Rethorst CD; Carmody TJ; Jha MK; Liao A; Grannemann BD; Chambliss HO; Church TS; Trivedi MH
    Depress Anxiety; 2016 Sep; 33(9):870-81. PubMed ID: 27164293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
    Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
    World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.
    Wall CA; Croarkin PE; Maroney-Smith MJ; Haugen LM; Baruth JM; Frye MA; Sampson SM; Port JD
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):582-9. PubMed ID: 26849202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial.
    Croarkin PE; Elmaadawi AZ; Aaronson ST; Schrodt GR; Holbert RC; Verdoliva S; Heart KL; Demitrack MA; Strawn JR
    Neuropsychopharmacology; 2021 Jan; 46(2):462-469. PubMed ID: 32919400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
    Demitrack MA; Thase ME
    Psychopharmacol Bull; 2009; 42(2):5-38. PubMed ID: 19629020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.
    Krstić J; Buzadžić I; Milanović SD; Ilić NV; Pajić S; Ilić TV
    J ECT; 2014 Dec; 30(4):325-31. PubMed ID: 24625704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases.
    Valiengo L; Benseñor IM; Goulart AC; de Oliveira JF; Zanao TA; Boggio PS; Lotufo PA; Fregni F; Brunoni AR
    Depress Anxiety; 2013 Jul; 30(7):646-53. PubMed ID: 23625554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis.
    Lan MJ; Chhetry BT; Liston C; Mann JJ; Dubin M
    Brain Stimul; 2016; 9(4):577-83. PubMed ID: 27017072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis.
    Rakesh G; Cordero P; Khanal R; Himelhoch SS; Rush CR
    J Affect Disord; 2024 Aug; 358():432-439. PubMed ID: 38740269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression: A Randomized Clinical Trial.
    Bergfeld IO; Mantione M; Hoogendoorn ML; Ruhé HG; Notten P; van Laarhoven J; Visser I; Figee M; de Kwaasteniet BP; Horst F; Schene AH; van den Munckhof P; Beute G; Schuurman R; Denys D
    JAMA Psychiatry; 2016 May; 73(5):456-64. PubMed ID: 27049915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
    Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
    Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial.
    Yip AG; George MS; Tendler A; Roth Y; Zangen A; Carpenter LL
    Brain Stimul; 2017; 10(4):847-849. PubMed ID: 28330592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral activation therapy during transcranial magnetic stimulation for major depressive disorder.
    Russo GB; Tirrell E; Busch A; Carpenter LL
    J Affect Disord; 2018 Aug; 236():101-104. PubMed ID: 29723763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.